Characterization of the effects of phosphorylation by CK2 on the structure and binding properties of human HP1β  by Munari, Francesca et al.
FEBS Letters 588 (2014) 1094–1099journal homepage: www.FEBSLetters .orgCharacterization of the effects of phosphorylation by CK2 on
the structure and binding properties of human HP1bhttp://dx.doi.org/10.1016/j.febslet.2014.02.019
0014-5793/ 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Abbreviations: CK2, casein kinase 2; CD, chromo domain; CSD, chromoshadow
domain; HP1, heterochromatin protein 1; MS, mass spectrometry; NMR, nuclear
magnetic resonance; SAXS, small angle X-ray scattering
⇑ Corresponding author at: German Center for Neurodegenerative Diseases
(DZNE) , Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, 37077
Göttingen, Germany.
E-mail address: markus.zweckstetter@dzne.de (M. Zweckstetter).Francesca Munari a,b, Michal Jan Gajda a, Kyoko Hiragami-Hamada c, Wolfgang Fischle c,
Markus Zweckstetter a,b,d,⇑
aDepartment for NMR-based Structural Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
bGerman Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
c Laboratory of Chromatin Biochemistry, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
dCenter for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), University Medical Center, Göttingen, Germany
a r t i c l e i n f o a b s t r a c tArticle history:
Received 9 December 2013
Revised 31 January 2014
Accepted 8 February 2014
Available online 20 February 2014







PhosphorylationProteins of the Heterochromatin Protein 1 (HP1) family are regulators of chromatin structure and
genome function in eukaryotes. Post-translational modiﬁcations expand the repertoire of the chem-
ical diversity of HP1 proteins and regulate their activity. Here, we investigated the effect of phos-
phorylation by Casein kinase 2 (CK2) on the structure, dynamics and binding activity of human
HP1b. We show that Ser89 in the hinge region is the most effective substrate, followed by Ser175
at the C-terminal tail. Phosphorylation at these sites results in localized conformational changes
in HP1b that do not compromise the ability of the protein to bind chromatin.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction nuclear proteins [2–4]. The long hinge region connecting CD toThe compaction of chromatin into different structural states, a
fundamental mechanism whereby eukaryotes tune the functions
of the genome, is a highly dynamic process subjected to different
levels of regulation. One of the most important is the post-
translational modiﬁcation of histone tails. Methylation of lysine 9
in histone H3 (H3K9me) is speciﬁcally recognized by Heterochro-
matin Protein 1 (HP1), a key player in chromatin condensation
and gene silencing. By means of its two distinct protein–protein
interactionmodules, the chromo domain (CD) and the chromoshad-
ow domain (CSD), HP1 links a variety of proteins involved in chro-
matin function. CD engages the H3K9me mark in nucleosomes [1],
while the dimeric CSD recruits different partners via recognition of
a consensus pentameric sequence PXVXL found in numerousCSD is highly dynamic [5,6] and has nucleic acid binding activity
[7,8]. Given the central role of HP1 in chromatin biology it is impor-
tant to understand how the protein is regulated.
Recent studies revealed that HP1 proteins are modiﬁed in
mammalian cells with the same variety of post-translational
modiﬁcations that mark the histones, such as phosphorylation,
acetylation and methylation [9–13]. Phosphorylation is one of
the prevalent modiﬁcations in HP1. Since the human HP1 homo-
logs a, b and c differ in the number of phospho-acceptors, differen-
tial phosphorylation could regulate their activity and localization.
Indeed, the three human HP1 proteins showed remarkable differ-
ences in phosphorylation patterns during the cell cycle [14].
Phosphorylation of HP1c by PKA [9] regulates HP1c silencing
activity, and HP1 proteins can be phosphorylated by members of
the TIF1 family and participate in their transcriptional repression
function [15]. In ﬁssion yeast, N-terminal phosphorylation of HP1
homolog Swi6 by Casein kinase 2 (CK2) was shown to control gene
silencing in heterochromatin [16]. The phosphorylation of the N-
terminal region of mammalian HP1a [17] and HP1 in Drosophila
[18] by CK2 regulates the binding and the proper targeting of these
proteins to heterochromatin. In addition, phosphorylation of T51 in
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damage by impairing the interaction of CDwithmethylated histone
[19]. Thus, phosphorylation by CK2, a pleiotropic and constitutively
active serine–threonine kinase with a global pro-survival activity
[20], constitutes an importantmechanismof regulation ofHP1 func-
tion. Identiﬁcation of the sites of CK2-mediated phosphorylation,
the degree of phosphorylation and the investigation of the effects
on the protein structure are therefore important to understand pos-
sible changes in the activity of HP1 at the molecular level.
Here, we studied the effects of phosphorylation on the struc-
tural and binding activity properties of human HP1b. We show that
S89 in the hinge region and S175, which is unique to HP1b among
the three human homologs, are the principal sites of modiﬁcation.
Upon phosphorylation, conformational changes occur around the
site of modiﬁcation. HP1b phosphorylated at S89 and S175 retains
its key activity of binding to histones and chromatin.2. Material and methods
Details on samples preparation and HP1b–chromatin binding
studies can be found in Supplementary information. For in vitro
phosphorylation of HP1b and its fragments we used recombinant
CK2 enzyme purchased from New England BioLabs. CK2 reactions
were done at room temperature in 20 mM Tris–HCl pH 7.5,
50 mM KCl, 10 mM MgCl2, 1 mM DTT, and ATP (Sigma) in molar
excess with respect to the substrate concentration (typically
10:1). Incubation time was 4 days for isotope-labeled HP1b, 5 days
for unlabeled HP1b and 7 days for CD, CSD and hinge fragments.
The NMR kinetic experiment was done at 298 K on a 0.17 ml
sample of 0.08 mM 15N-perdeuterated HP1b in the previously de-
scribed CK2 buffer at pH 7 and with 0.6 mM ATP, by acquiring
thirty 1H–15N HSQC of 40 min each after addition of 2500U of
CK2. A 3 mm tube and a 700 MHz spectrometer equipped with
cryoprobe were used. To derive the characteristic signal decay
times, the intensity of original peaks as a function of incubation
time was ﬁtted to a single-exponential decay equation.
Additional experimental details can be found in Supplementary
information.
3. Results and discussion
An overview of the phosphorylated sites found in human HP1b
and occurring in cells is available at the ‘‘PhosphoSitePlus,
www.phosphosite.org’’ resource [21], and is illustrated in Fig. 1A.
Part of the phosphorylated sites conforms to the consensus motif
of CK2 substrates. Multiple acidic residues between the 1 and
+4 position relative to the phospho-acceptor (Ser is favored over
Thr) deﬁne a strong motif for CK2. The most relevant acidic deter-
minant is at +3, followed by the +1 position. Basic residues are neg-
ative determinants between 1 and +4, as well as Pro at +1 [20].
Following these criteria, S46, S89 and S175 are closest to the opti-
mal consensus phosphorylation sequence. Based on the general ac-
cepted motif S/TXXE/D, T73, S128 and S162 are additional
potential CK2 substrates, although they lack the favoring +1 acidic
determinant. Since variants like SXE/D or sites that depend on pre-
vious phosphorylation events, were also found among the hun-
dreds of CK2 protein substrates [20], additional CK2-sites might
be present in HP1b. Indeed T51, although residing in an atypical
motif, was found to be phosphorylated by CK2 [19].
The ability of CK2 to phosphorylate recombinant human HP1b
in our experimental conditions was initially assessed by mass
spectrometry (MS). After in vitro phosphorylation of HP1b by
CK2, MS analysis revealed a main double- phosphorylated species.
The second notable signal indicated also the presence of triple-
phosphorylated isoforms (Fig. 1B). To identify the phospho-acceptorsites, quantify themodiﬁcation level and investigate at atomic reso-
lution the possible structural changes derived fromphosphorylation
of HP1, we used NMR spectroscopy. NMR is an excellent method for
the studyof post-translationalmodiﬁcations of proteins as the cova-
lent addition of chemical groups can be probed by highly speciﬁc
changes in both the position and intensity of signals uniquely asso-
ciated with speciﬁc residues. In particular, 1H–15N correlations are
highly sensitive to local changes of chemical environment directed
by protein phosphorylation. The reaction of CK2 on 15N-perdeuter-
ated HP1b sample resulted in changes for a subset of signals in the
1H–15N HSQC spectrum. The region including serine signals was
mainly affected, and two new intense peaks appeared in the down-
ﬁeld direction (Fig. 2A), suggesting the occurrence of amain double-
phosphorylated isoform, in agreement with MS. Nearby, two very
small peaks also appeared (Fig. S1A), indicating the presence of rare
isoforms that can correspond to the triple-phosphorylated species
detected by MS.
NMR signals of residues within the CD and CSD were mainly
unperturbed, suggesting that the obtained phosphorylation caused
little effect on the globular domains of HP1b. Changes were ob-
served primarily in the part of the spectrum belonging to the un-
folded regions. Since peaks shift not only as a consequence of
direct phosphorylation but also in consequence of indirect changes
induced by the nearby phosphorylation sites, we carried out mul-
tidimensional triple-resonance experiments to unambiguously as-
sign the backbone resonances of the prevalent double-
phosphorylated isoform. Fig. 3A shows the plot of HP1b 1H–15N-
backbone chemical shifts changes as a consequence of protein
phosphorylation. While the N-terminal tail, the CD and most of
the CSD did not show signiﬁcant changes, the hinge region and
the C-terminal part, including the very end of CSD, were perturbed.
The most affected signals correspond to S89 and S175 and the
neighboring residues, which comply with the optimal consensus
sequence motif of CK2. As shown in Fig. 2A, S89 and S175 experi-
enced large downﬁeld backbone 1H/15N chemical shift changes
(0.51/1.54 ppm and 0.44/0.87 ppm, respectively), with the magni-
tude and direction being typical for phosphorylated serine residues
in solvent exposed regions [22]. These features, together with the
observation that the original peaks corresponding to the unmodi-
ﬁed variant almost vanished (94% and 92% were phosphorylated,
respectively), indicate that S89 and S175 are the two principal sites
of phosphorylation. The small additional signals appearing next to
pS89, probably belonging to the triple-phosphorylated isoforms
detected by MS, could not be assigned due to low signal intensity
(4% relative to pS89), indicative of sub-stoichiometric levels of
modiﬁcation in the NMR sample.
To identify the position of the third phospho-acceptor site, we
incubated CK2 with two different HP1 fragments containing the
residues that were mainly perturbed as shown by the previous
NMR analysis of full-length HP1b (2–185): a hinge region peptide,
spanning residues 80–109, and a CSD containing protein, spanning
residues 107–185. For the latter construct, one phosphorylated site
was detected by MS and NMR and conﬁrmed to be S175 (Figs. 1B
and 4A). The incubation of CK2 with the hinge peptide resulted in
a major mono-phosphorylated species together with a secondary
component corresponding to a double-phosphorylated peptide
(Fig. 1B). Thus, a third phosphorylation site of full-length HP1b is lo-
cated in the hinge region. It might correspond to S91, which is with-
in a sequence variant substrate (SXE/D) for CK2 and was found, in
addition to S89 and S175 [10,12,13], to be phosphorylated in hu-
man cells [12,13]. However, NMR data obtained in the context of
full-lengthHP1b indicated that S91 remainedmainly in the unmod-
iﬁed state and isoforms phosphorylated at this site were relatively
rare. Indeed for S91 we did not observe the large downﬁeld chem-
ical shift typical of phospho-serine (Fig. 2A). Its moderate shift in-
stead reﬂects the proximity to the neighboring pS89 (see below).
Fig. 1. Phosphorylation of human HP1b. (A) Primary structure of human HP1b (UniProt ID: P83916). Previously identiﬁed phosphorylation sites listed at ‘‘PhosphoSitePlus,
www.phosphosite.org’’ [21] are numbered and marked in black. Regions corresponding to the CK2 consensus motif ‘S/TXXD/E’ are underlined. CD and CSD are highlighted in
green and blue respectively. (B) MS analysis of proteins before (left side of each panel) and after (right side of each panel) incubation with CK2. HP1: HP1b(2–185); Hinge:
synthetic peptide Hinge(80–109); CSD: 15N-CSD(GHM107–185); CD: 15N-CD(G19–79). Note the contribution of 15N-labeling (close to 100%) to the mass of CD and CSD
samples.
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using NMR spectroscopy. During incubation for 1 day, the kinetics
of ‘‘substrate consumption’’ upon phosphorylation differed signiﬁ-
cantly at individual sites (Fig. 2B). The signal decay times of S89
and S175 upon reaction were 5.2 ± 0.1 and 9.7 ± 0.7 h, respectively.
Thus, phosphorylation of S89 in the hinge region is faster than that
of S175. This difference may arise from better solvent exposure of
the hinge region, while access to S175 might be hindered by the
neighboring CSD. The signal decay time of S91 was 5.2 ± 0.2 h
(Fig. S1B). The similarity of the decay times of S91 and S89 suggests
that the signal perturbation observed for S91 is caused by a change
of chemical environment due to phosphorylation at S89 and not
due to a direct modiﬁcation.
As a negative control, other residues were analyzed. Interest-
ingly S46, that ﬁts the CK2 criteria to be an optimal substrate, does
not show any change in signal position, nor in intensity. This isprobably because the consensus sequence is embedded in the CD
fold and therefore not accessible. Also T51, identiﬁed as CK2 sub-
strate in a recent study by different experimental strategies [19],
did not show any clear NMR signal change in our experimental
conditions. To explore the possibility that in full-length protein
the strong competition with the main sites located in the hinge re-
gion and C-terminus impeded phosphorylation in CD, we assayed
CK2 activity on the isolated construct CD (19–79). MS results sug-
gested the occurrence of partial phosphorylation (Fig. 1B). How-
ever, the majority of the protein remained unmodiﬁed in our
experimental conditions, suggesting that phosphorylation of CD
was not efﬁcient. The fact that T51 is within the CD fold and resides
in an atypical sequence for CK2 recognition is consistent with the
low level of modiﬁcation at this site. In a cellular context phos-
phorylation of T51 by CK2 might be boosted by speciﬁc molecular
events. For example, possible protein–protein interactions induced
Fig. 2. NMR analysis of HP1b phosphorylation by CK2. (A) Superposition of a selected region from the 1H–15N TROSY HSQC spectrum of HP1b (blue) and HP1b after
phosphorylation by CK2 (red). The new signals, corresponding to the phosphorylated counterpart of S89 and S175, are labeled with pS89 and pS175. (B) Time course of the
phosphorylation reaction monitored by substrate consumption based on the relative changes in peak intensity. Errors were determined through propagation of the noise in
the NMR spectra.
Fig. 3. Conformational analysis of phosphorylated HP1b (pHP1b). (A) Combined
1H–15N chemical shift differences between pHP1b and HP1b. (B) 13C carbonyl
chemical shift differences between pHP1b and HP1b. The scatter observed in the
CSD is due to the lower signal-to-noise ratio caused by the slower tumbling of the
dimeric CSD. Signals affected by severe overlap or broadening were excluded from
the analysis. (C) Steady-state 1H–15N hetNOE measured on full-length HP1b (black)
and pHP1b (red) using 10 s recycle delay.
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the CD or induce local conformational changes that make T51 more
accessible for the enzyme catalysis.
NMR was further used to investigate the effects of S89 and S175
modiﬁcation on the conformational properties of the prevalent
double-phosphorylated HP1b isoform. Analysis of combined
1H–15N chemical shift differences (Fig. 3A) indicated that the over-
all structure of neither CD nor CSD was affected. On the other hand,
analysis of 13C carbonyl (13C’) chemical shifts, highly sensitive
probes of protein conformation, showed that phosphorylation at
S89 and S175 induced local conformational changes (Fig. 3B)
around the phospho-sites. The decrease of 13C’ chemical shift val-
ues observed for the residues preceding the phosphorylated ser-
ines of pHP1, relative to the unmodiﬁed protein, suggests a shift
in the conformational ensemble of this region toward more ex-
tended structures. A reverse effect was observed for the residues
following the phospho-sites. Moreover, steady-state 1H–15N heter-
onuclear NOEs analysis, reporting on NH-bond motion in the pico-
second-to-nanosecond timescale, showed a localized alteration in
the hinge region (Figs. 3C and S1C). Between residues 87 and 95,
a 0.1–0.2 rise was observed, indicating that upon S89 phosphor-
ylation, this segment partially loses its mobility. This feature seems
to be site-speciﬁc, as residues around S175 at the C-terminal tail
did not show the same effect. The local conformational changes ob-
served around the phospho-sites were not accompanied by a per-
turbation in the global size of the molecule or its assembly state, as
the SAXS-derived radius of gyration of HP1b and pHP1b was com-
parable (Fig. S1D).
The chemical shift analysis (Fig. 3A and B) suggested that the
conformational perturbation in proximity to pS175 might expand
up to the C-terminus of the CSD. In addition, the C-terminal tail
was shown to cooperate with CSD for binding selectivity in HP1a
of Drosophila melanogaster [23]. To evaluate a possible inﬂuence
of S175 phosphorylation on CSD binding activity, we carried out
NMR interaction experiments using a CSD construct, which ex-
tends up to the HP1b C-terminus (residues 107–185), and a histone
H3 (35–67) peptide containing the CSD binding ‘shadock’ motif
[24,25]. Fig. 4A–C shows that the interaction of CSD/pCSD with
the peptide signiﬁcantly perturbed residues belonging to the two
groups 124–127 and 163–173, consistent with the speciﬁc PXVXL
binding interface described for the NMR structure of CSD bound
to CAF-1 peptide [4]. Thus, phosphorylation at S175 does not com-
promise the shadock peptide binding functionality of CSD. How-
ever, a small difference in the relative intensities suggests that
binding of pCSD is slightly less efﬁcient. To evaluate the effect of
phosphorylation on the binding of full-length HP1b to its cognate
Fig. 4. Analysis of phosphorylated chromoshadow domain of HP1b. (A) Superposition of a selected region of the 1H–15N TROSY HSQC spectrum of CSD(107–185) in the free
state (left, blue) and bound to shadock peptide (left, cyan), and pCSD(107–185) in the free state (right, red) and bound to shadock peptide (right, green). (B) Intensity loss of
residues in CSD (black) and pCSD (red) in 1H–15N TROSY HSQC spectra upon addition of the shadock peptide (HP1:peptide at 10:1 molar ratio). (C) Intensity ratio values
smaller than 0.7 from analysis of CSD in complex with peptide of panel B, are mapped in red onto the 3D structure of CSD in complex with CAF-1 peptide (marked in light
blue) (PDB ID: 1s4z [4]). (D) Co-precipitation of HP1b/pHP1b with unmodiﬁed and H3Kc9me3 12-mer oligonucleosomal array. The Coomassie-stained SDS–PAGE gel is
shown.
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using recombinant 12-mer oligonucleosomal arrays. The results
in Fig. 4D show that HP1b phosphorylated at S89 and S175 fully re-
tained its ability to bind the H3Kc9me3 chromatin template. This is
in line with the dominant role of CD for this interaction [8].
In human HP1b, substitution of S89/S91 and S172/S175 by ala-
nine did not impair its localization to chromatin [19]. In the Dro-
sophila homolog of HP1, on the other hand, mutagenesis of the
CK2 consensus sites S15 and S202 interfered with HP1 heterochro-
matin targeting and silencing activity, and impaired the binding to
DNA [18,26]. In addition, the hinge region of HP1 was shown to
bind non-speciﬁcally to nucleic acids [7,8]. Thus, phosphorylation
of S89, in combination with additional phospho-acceptors such
as S91, might modulate HP1b diffusion along chromatin due to al-
tered protein–DNA electrostatic interactions. Phosphorylation of
S175, which is not conserved in other human HP1 homologs, might
also provide a way to selectively modulate the binding to partners
that speciﬁcally recognize the human HP1b C-terminus. This would
constitute a potential mechanism to regulate the signaling-depen-
dent HP1 activities unique to the b variant.
In summary, we provided high-resolution information of the ef-
fects of CK2-mediated phosphorylation on the structure, dynamics
and binding activity of human HP1b. NMR spectroscopy allowed us
to identify the primary sites of CK2 and determine the enzyme
preference for individual sites. Although protein modiﬁcation by
CK2 induces backbone conformational changes around S89 and
S175, the main sites of phosphorylation, HP1b phosphorylated at
these sites retains its fundamental activity of binding methylated
chromatin.
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